Herbst Group LLC Acquires 800 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Herbst Group LLC boosted its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 19.9% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 4,830 shares of the exchange traded fund’s stock after acquiring an additional 800 shares during the period. Herbst Group LLC’s holdings in SPDR S&P Biotech ETF were worth $435,000 at the end of the most recent quarter.

Several other large investors have also added to or reduced their stakes in the business. Hartline Investment Corp increased its position in shares of SPDR S&P Biotech ETF by 2.0% in the third quarter. Hartline Investment Corp now owns 5,502 shares of the exchange traded fund’s stock worth $544,000 after purchasing an additional 106 shares during the last quarter. Signature Estate & Investment Advisors LLC grew its stake in shares of SPDR S&P Biotech ETF by 5.7% during the 3rd quarter. Signature Estate & Investment Advisors LLC now owns 2,336 shares of the exchange traded fund’s stock valued at $231,000 after purchasing an additional 125 shares during the period. Denver Wealth Management Inc. boosted its position in shares of SPDR S&P Biotech ETF by 0.9% in the third quarter. Denver Wealth Management Inc. now owns 14,779 shares of the exchange traded fund’s stock worth $1,460,000 after purchasing an additional 127 shares during the period. Resources Management Corp CT ADV raised its stake in SPDR S&P Biotech ETF by 30.3% during the 2nd quarter. Resources Management Corp CT ADV now owns 593 shares of the exchange traded fund’s stock valued at $55,000 after purchasing an additional 138 shares during the period. Finally, Trust Co. of Vermont increased its holdings in shares of SPDR S&P Biotech ETF by 4.7% in the third quarter. Trust Co. of Vermont now owns 3,058 shares of the exchange traded fund’s stock worth $302,000 after purchasing an additional 138 shares during the last quarter.

SPDR S&P Biotech ETF Stock Performance

NYSEARCA:XBI opened at $87.97 on Friday. The stock’s fifty day moving average is $94.09 and its 200 day moving average is $96.94. SPDR S&P Biotech ETF has a fifty-two week low of $81.14 and a fifty-two week high of $105.47. The firm has a market capitalization of $6.71 billion, a PE ratio of 11.47 and a beta of 1.11.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.